When was Brain Gaze founded?

Brain Gaze was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is Brain Gaze located?

Brain Gaze is headquartered in Mataro, Spain.

Who is the current CEO of Brain Gaze?

Laszlo Bax of Brain Gaze. They have also founded 1 company.

How many employees does Brain Gaze have?

As of Mar 31, 2026, the latest employee count at Brain Gaze is 10.

Is Brain Gaze a funded company?

Brain Gaze is a funded company, having raised a total of $2.23M across 7 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 23, 2014.

When was the latest funding round of Brain Gaze?

Brain Gaze's latest funding was a $***** Seed round on Mar 06, 2024, with participation from 3 investors.

Where does Brain Gaze rank among its competitors?

Brain Gaze ranks 18th amongst 88 active competitors, of which 29 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was neuroClues, which secured $11.6M in Apr, 2026.

Who are the top competitors of Brain Gaze?

Brain Gaze's top competitors include Neuralight, neuroClues and Tobii Dynavox. Among them, neuroClues secured the most recent funding round in April, 2026.

Brain Gaze - 2026 Company Profile, Team, Funding & Competitors

Company Details

Eye tracking software provider for personal behavior testing and ADHD diagnosis. It uses its Cognitive Vergence which is based on the predictive power of small eye movements as a marker for cognitive visual processing. The method is non-invasive and can be integrated into existing eye-tracking devices and software. The company also provides a clinical test product BGaze ADHD, which offers a testing solution for ADHD based on an involuntary eye movement biomarker that reflects specific traits of the hard wiring of a persons brain.

Website: braingaze.com
Social
Email ID: *****@braingaze.com
Phone Number: +34 **********

Key Metrics

Founded Year

2013

Location

Mataro, Spain

Stage

Seed

Total Funding

$2.23M in 7 rounds

Latest Funding Round

Seed, Mar 06, 2024, $*****

Investors

RYSE Asset Management & 7 more

Ranked

18^th among 88 active competitors

Employee Count

10 as on Mar 31, 2026

Similar Companies

Neuralight & 90 more

View Brain Gaze's full profile

Brain Gaze has raised a total funding of $2.23M over 7 rounds. Its first funding round was on Jul 23, 2014. Its latest funding round was a Seed round on Mar 06, 2024 for $*****. 3 investors participated in its latest round. Brain Gaze has 8 institutional investors.

Here is the list of recent funding rounds of Brain Gaze:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 06, 2024	2353508	Seed	4844941	6516401	2328516	7964900
Jun 10, 2020	9708944	Seed	7800744	3723687	3277870	Orbit Ventures
Apr 30, 2020	5491552	Grant (prize money)	7328858	6280946	1356566	EIC Fund

Access funding benchmarks and valuations. Sign up today!

View details of Brain Gaze's funding rounds and investors

The founders of Brain Gaze are Hans Super and Laszlo Bax.

Here are the details of Brain Gaze's key team members:

Hans Super: Co-Founder & CTO of Brain Gaze and founder of 1 other company.
Contact Info: 1 email address
Laszlo Bax: Co-Founder And Ceo of Brain Gaze.

View details of Brain Gaze's Founder profiles and Board Members

Brain Gaze's employee count trend

Brain Gaze has 10 employees as of Mar 26. Here is Brain Gaze's employee count trend over the years:

Uncover Brain Gaze's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Brain Gaze include Neuralight, neuroClues and Tobii Dynavox. Here is the list of Top 10 competitors of Brain Gaze, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Neuralight 2021, San Francisco (United States), Series A	AI-based neurological evaluation and assessment tool for diagonosis	$30.5M	Koch Disruptive Technologies, Breyer Capital ... & 17 others	60/100
2nd	neuroClues 2020, Louvain-la-neuve (Belgium), Series A	Provider of eye-tracking devices for healthcare practitioners	$21.8M	Graph Ventures, Teampact Ventures & 11 others	54/100
3rd	Tobii Dynavox 1983, Danderyd (Sweden), Public	Provider of assistive communication solution for differently abled people via eye-tracking	-	Vestar Capital Partners	53/100
4th	NovaSight 2016, Lod (Israel), Series B	Provider of eye-tracking-based solutions for vision assessment and treatment	$20M	Rimonci, EIT Health	51/100
5th	Neurotrack 2012, Redwood City (United States), Series C	Provider of clinical assessment tool to diagnose neurological disorders	$57.8M	Khosla Ventures, Sozo Ventures & 17 others	50/100
6th	Rebion 2009, Boston (United States), Seed	Provider vision scanning devices to diagnose brain diseases	$7.46M	MassChallenge, NIH & 2 others	50/100
7th	NeuroSync Washington, DC (United States), Series A	Provider of AI-based platform to assess brain health, deliver therapy, and optimize performance	$7.43M	Quadrant, Oceanic Partners & 4 others	47/100
8th	EyeControl 2014, Tel Aviv (Israel), Series A	Eye controled communication device solution for ALS patients	$7.5M	Connecticut Innovations, Menomadin Foundation ... & 13 others	47/100
9th	C. Light Technologies 2014, Berkeley (United States), Seed	Developer of eye-tracking solution provider to detect and monitor neurodegenerative diseases	$3.25M	Creative Ventures, Alzheimer's Drug Discovery ... & 10 others	46/100
10th	Irisbond 2013, San Sebastian (Spain), Series A	Developer of eye tracking solution to control a computer for disabled individuals	$7.03M	BBVA Momentum, Bind 4.0 & 3 others	45/100
18th	Brain Gaze 2013, Mataro (Spain), Seed	Eye tracking software provider for personal behavior testing and ADHD diagnosis	$2.23M	Orbit Ventures, EIT Health & 6 others	39/100